SEARCH

SEARCH BY CITATION

References

  • 1
    Balduini, C.L., Guarnone, R., Pecci, A., Centenara, E., Rosangela, I., Ascari, E. (1999) The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica, 84, 12 16.
  • 2
    Benitez, J., Rous, G.P., Fayos, J.S. (1991) Prognostic value of complex karyotypes in patients with simple refractory anemia. Cancer Genetics and Cytogenetics, 53, 279 280.
  • 3
    Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C. (1985) The French-American-British Co-operative Group: proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189 199.
  • 4
    Berger, R., Bernheim, A., Le Coniat, M., Vecchione, D., Pacot, A., Daniel, M.-T., Flandrin, G. (1986) Abnormalities of the short arm of chromosome 12 in acute nonlymphocytic leukemia and dysmyelopoietic syndrome. Cancer Genetics and Cytogenetics, 19, 281 289.
  • 5
    Dixon, W.J. (ed.) (1983) BMPD Statistical Software. University of California Press, Berkeley.
  • 6
    Estey, E., Keating, M., Pierce, S., Beran, M. (1997) Application of the International Scoring System for myelodysplasia to M.D. Anderson patients. Blood, 90, 2843 2844.
  • 7
    Fenaux, P., Morel, P., Lai, J.-L. (1996) Cytogenetics of myelodysplastic syndromes. Seminars in Hematology, 33, 127 138.
  • 8
    Greenberg, P., Cox, C., Le Beau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespí, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G., Bennett, J.M. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079 2088.
  • 9
    ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). S. Karger, Basel.
  • 10
    Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
  • 11
    Knapp, R.H., Dewald, G.M., Pierre, R.V. (1985) Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clinical Proceedings, 60, 507 516.
  • 12
    Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163 170.
  • 13
    Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F., Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia, 7, 1315 1323.
  • 14
    Mufti, G.J., Stevens, J.R., Oscier, D.G., Hamblin, T.J., Machin, D. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology, 59, 425 433.
  • 15
    Musilova, J. & Michalova, K. (1988) Chromosome study of 85 patients with myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 33, 39 50.
  • 16
    Nowell, P.C. & Besa, E.C. (1989) Prognostic significance of single chromosome abnormalities in preleukemic states. Cancer Genetics and Cytogenetics, 42, 1 7.
  • 17
    Parlier, V., Van Melle, G., Beris, P., Schmidt, P.M., Tobler, A., Haller, E., Jotterand Bellomo, M. (1994) Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings. Cancer Genetics and Cytogenetics, 78, 219 231.
  • 18
    Parlier, V., Van Melle, G., Beris, P., Schmidt, P.M., Tobler, A., Haller, E., Jotterand Bellomo, M. (1995) Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score. Cancer Genetics and Cytogenetics, 81, 158 165.DOI: 10.1016/0165-4608(94)00220-6
  • 19
    Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.W., Mantel, N., McPherson, K., Peto, J., Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observations of each patient. British Journal of Cancer, 35, 1 39.
  • 20
    Pfeilstöcker, M., Reisner, R., Nösslinger, T., Grüner, H., Nowotny, H., Tüchler, H., Schlögl, E., Pittermann, E., Heinz, R. (1999) Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics. British Journal of Haematology, 106, 455 463.
  • 21
    Pierre, R.V., Catovsky, D., Mufti, G.J., Swansbury, G.J., Mecucci, C., Dewald, G.W., Ruutu, T., Van Den Berghe, H., Rowley, J.D., Mitelman, F., Reeves, B.R., Alimena, G., Garson, O.M., De Lawler, S.D., La Chapelle, A. (1989) Clinical–cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genetics and Cytogenetics, 40, 149 161.
  • 22
    Sanz, G.F., Sanz, M.A., Vallespí, T., Can~izo, M.C., Torrabadella, M., García, S., Irriguible, D., San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395 408.
  • 23
    Second International Workshop on Chromosomes in Leukemia 1979 (1980) Chromosomes in preleukemia. Cancer Genetics and Cytogenetics, 2, 108 113.
  • 24
    Solé, F., Prieto, F., Badia, L., Woessner, S., Florensa, L., Caballín, M.R., Coll, M.D., Besses, C., Sans-Sabrafen, J. (1992) Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genetics and Cytogenetics, 64, 12 20.
  • 25
    Solé, F., Woessner, S., Florensa, L., Pérez-Losada, A., Acín, P., Besses, C., García-Eroles, L., Sans-Sabrafen, J. (1998) Estudio citogenético en 93 síndromes mielodisplásicos. Medicin Clinica (Barcelona), 110, 94 98.
  • 26
    Suciu, S., Kuse, R., Weh, H.J., Hossfeld, D.K. (1990) Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 44, 15 26.
  • 27
    Third MIC Co-operative Study Group 1987 (1988) Morphologic, immunologic, and cytogenetic (MIC) working classification of the primary myelodysplastic syndromes and therapy-related myelodysplasias leukemias. Cancer Genetics and Cytogenetics, 32, 1 10.
  • 28
    Toyama, K., Ohyashiki, K., Yoshida, Y., Abe, T., Asano, S., Hirai, H., Hirashima, K., Hotta, T., Kuramoto, A., Kuriya, Sh., Miyazaki, T., Kakishita, E., Mizoguchi, H., Okada, M., Shirakawa, Sh., Takaku, F., Tomonaga, M., Uchino, H., Yasunaga, K., Nomura, T. (1993) Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia, 7, 499 508.
  • 29
    Vallespí, T., Imbert, M., Mecucci, C., Preudhomme, C., Fenaux, P. (1998) Diagnosis, classification, and cytogenetics of myelodysplastic syndromes. Hematologica, 83, 258 275.
  • 30
    Weh, H.J., Calavrezos, A., Seeger, D., Kuse, R., Hossfeld, D.K. (1987) Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS). European Journal of Haematology, 38, 166 172.
  • 31
    Wilmoth, D., Feder, M., Finan, J., Nowell, P.C. (1985) Preleukemia and leukemia with 12p− and 19q+ chromosome alterations following Alkeran therapy. Cancer Genetics and Cytogenetics, 15, 95 98.
  • 32
    Yunis, J.J., Lobell, M.L., Arnesen, M.A., Oken, M.M., Mayer, M.G., Rydell, R.E., Brunning, R.D. (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology, 68, 189 194.